Skip to main content
Fig. 2 | Proteome Science

Fig. 2

From: A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach

Fig. 2

Principal Component Analysis (PCA) of the proteome data in a 3D-plot. Group of sample sets that are close together are highly correlated in terms of the proteome profile for each condition while the group of distant sample sets is less correlated. Different treatment conditions are indicated by different-colored circles; Gefitinib-treated samples are marked with a brown dot, R9VH36-treated samples with a green dots, and the control-samples with red dots

Back to article page